Fermenta Biotech has informed that meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, November 13, 2019, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter and half year ended September 30, 2019. Pursuant to the earlier Notice for the Closure of Trading Window dated October 1, 2019 and in accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders and in terms of Circular LIST/COMP/01/2019-20 dated April 2, 2019, the 'Trading Window' (period for trading in Company’s securities) has already been closed with effect from October 1, 2019 and shall continue to remain closed till 48 hours after declaration of financial results.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1804.50 |
Dr. Reddys Lab | 1201.45 |
Cipla | 1551.30 |
Lupin | 2104.90 |
Zydus Lifesciences | 879.85 |
View more.. |